stockportfolio.pro
Stocks / ACTG vs ASPN
ACTG vs ASPN
Acacia Research Corporation and Aspen Aerogels, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Industrials.
| Acacia Research Corporation (ACTG) | Aspen Aerogels, Inc. (ASPN) | |
|---|---|---|
| Market cap | $0.4B | $0.5B |
| Revenue (latest FY) | $285.23M | $271.10M |
| Net income (latest FY) | $21.68M | $-389.55M |
| Revenue growth (5y CAGR) | 57.1% | 22.0% |
| Net margin | 7.6% | -143.7% |
| Return on equity | 4.0% | -165.4% |
| P/E ratio | — | — |
| Dividend yield | — | — |
| Profitable years (of last 10) | 5 | 1 |
| Positive free cash flow | Yes | No |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open ACTG — free Open ASPN — freeFrequently asked questions
Which is bigger, ACTG or ASPN?
Aspen Aerogels, Inc. is larger by market capitalization — $0.5B versus $0.4B.
Which grows faster, ACTG or ASPN?
Over the last five fiscal years, Acacia Research Corporation grew revenue faster — 57.1%/yr versus 22.0%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.